
Real-world data services to drive brand success

With over 70 million patient interactions across Europe, Sciensus provides real-world data services that deliver high-quality, real-time insights. Our expertise in patient engagement and data analytics ensures that pharmaceutical companies, regulators, and healthcare professionals can make informed decisions that drive better health outcomes.
Our world-class expertise combined with a deep understanding of evidence requirements and industry leading digital solutions, can help you collect, generate, and communicate invaluable real-world evidence (RWE). This evidence underpins a wide range of activities, including securing market access, supporting regulatory submissions, optimising brand launches, conducting post-marketing safety studies and informing patient-level healthcare decision-making.
What is real-world data in healthcare?
Real-world data reveals how treatments perform in everyday clinical practice, drawing on data collected from actual patient care rather than controlled clinical trials. While traditional clinical trials take place in controlled research environments, RWD comes from diverse sources including electronic health records, insurance claims, disease registries, wearable devices and patients’ own reported experiences.
Real-world data (RWD) is a critical asset in pharmaceutical innovation and research, enabling a deeper understanding of patients’ needs and driving the development of more effective therapies and personalised healthcare solutions. RWD is essential for demonstrating treatment value – ultimately leading to better patient outcomes and commercial success.
What’s the difference between real-world data and real-world evidence?
While real-world data refers to the raw unprocessed data collected from real-world sources, real-world evidence is generated from this data to answer or shed light on a specific research question. Sources include:
- Electronic health records (EHRs)
- Insurance claims & billing data
- Patient-reported outcomes & wearable devices
- Disease registries & observational studies
Real-world evidence (RWE) transforms the RWD collected during routine patient care into powerful insights about a treatment’s effectiveness and safety across diverse patient populations, helping healthcare stakeholders make more informed decisions about long-term treatment approaches.
Benefits of real-world data collection for pharmaceutical companies
Our real-world data services help to show how drugs perform in real-world conditions, where patient adherence, comorbidities, and varying demographics play a role. Post-marketing surveillance helps detect rare or long-term adverse effects.

Understanding real-world effectiveness
Our real-world data services help to show how drugs perform in real-world conditions, where patient adherence, comorbidities, and varying demographics play a role. Post-marketing surveillance helps detect rare or long-term adverse effects.

Supporting regulatory decisions
By harnessing RWD, pharmaceutical companies can demonstrate the real-world effectiveness and cost-efficiency of their products, supporting new indications, formulations, or faster regulatory approvals.

Improving market access and reimbursement
RWD provides evidence for cost-effectiveness and value-based pricing which is critical for negotiations with payers. This can be especially helpful for high-cost drugs.

Real-world data vs. real-world evidence
Feature | Real-World Data (RWD) | Real-World Evidence (RWE) |
Definition | Raw data collected from real-world sources | Insights derived from analysing RWD |
Sources | EHRs, claims data, patient-reported data | Clinical studies, market access reports |
Use case | Data collection | Supporting regulatory & clinical decisions |
Real-world data is the foundation, while real-world evidence translates this data into actionable insights for regulatory submissions, market access, and clinical decision-making.

Sciensus’ unique solution
Sciensus, sitting at the intersection of patients and their medications, is uniquely positioned to draw on 30 years of patient interactions across Europe to generate this crucial insight.
Every day we’re trusted to engage directly with patients, both in person and through digital solutions, enabling us to gather real-time, high-quality patient-reported data. This forms the backbone of our real-world data services.
Our expertise gives us a deep understanding of complex treatment regimens, spanning across:
We harness this expertise and insight to develop and deliver innovative patient interventions to support clinicians and pharmaceutical companies throughout the region to drive brand success and better outcomes for patients.
Our unique real-world data services cover
End-to-end study management
From observational to interventional and non-interventional studies, we expertly manage every stage of your research, ensuring high-quality results for regulatory submissions and publications.
Real-world evidence insights
We deliver actionable evidence through robust data analytics, answering key research questions and supporting evidence generation for regulatory and clinical outcomes.
Post-market surveillance & pharmacovigilance
Our dedicated pharmacovigilance team monitors adverse events, ensuring continuous safety surveillance beyond market approval.
Longitudinal patient tracking
We provide a full patient journey view, enabling you to analyse persistence, adherence, and long-term outcomes to enhance treatment strategies.
Direct patient engagement
Our integrated digital platforms capture real-time, high-quality patient-reported data from patients across Europe, offering insights into patient experiences and treatment impact.
Therapeutic expertise
With deep knowledge in oncology, rare diseases, and chronic conditions, we understand complex treatment regimens and the clinical context needed for accurate data interpretation.
Start transforming patient support today
Partner with Sciensus to drive increased adherence through holistic patient support programs. Contact our team to schedule a consultation.
Expertise that makes the difference
With our clinical expertise, primary source access to patients, experience and insights, no one knows patients like we do.
0
Years’ experience in Europe
0
Patients supported each year
0
Million direct patient interactions
0
Patients active on our apps
Learn more about how real-world data drives success
Through a collection of whitepapers, case studies, and expert insights, we showcase the power of data in shaping impactful, data-driven outcomes.

Thought Leadership
Get the free whitepaper: How early access programs & real-world data help Biotechs succeed

Blogs
Real-world data and shaping the future of healthcare
Real-world data’s role in healthcare strategy and pharma decision-making Here are two of the key ways in which RWD can…

Thought Leadership
Unleashing valuable patient insights: The transformative power of patient reported data.